Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jul 10;115(28):E6388-E6389.
doi: 10.1073/pnas.1808092115. Epub 2018 Jun 25.

How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

Go J Yoshida  1
Affiliations
Comment

How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

Go J Yoshida. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Comment in

Comment on

References

    1. Qin X-Y, et al. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci USA. 2018;115:4969–4974. - PMC - PubMed
    1. Nio K, Yamashita T, Kaneko S. The evolving concept of liver cancer stem cells. Mol Cancer. 2017;16:4. - PMC - PubMed
    1. Beltran H. The N-myc oncogene: Maximizing its targets, regulation, and therapeutic potential. Mol Cancer Res. 2014;12:815–822. - PubMed
    1. Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W. E2F and Sp1/Sp3 synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem. 2004;279:5110–5117. - PubMed
    1. Suenaga Y, et al. NCYM, a cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet. 2014;10:e1003996. - PMC - PubMed

Substances

LinkOut - more resources